Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. [electronic resource]
- Metallomics : integrated biometal science Jan 2016
- 43-60 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1756-591X
10.1039/c5mt00181a doi
Antineoplastic Agents--chemistry Drug Delivery Systems Humans Nanotechnology--methods Neoplasms--drug therapy Platinum--chemistry